TEA TREE OIL

TEA TREE OIL was reported 190 times

TEA TREE OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS 1 0.1250
1 ACARIASIS 1 0.0714
2 OCULAR DEMODICOSIS 1 0.0208
3 PUNCTURE SITE INFECTION 1 0.0161
4 TYPE II HYPERSENSITIVITY 1 0.0084
5 EYELASH CHANGES 1 0.0056
6 ANTIBODY TEST NEGATIVE 1 0.0051
7 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
8 LICE INFESTATION 1 0.0048
9 ENVIRONMENTAL EXPOSURE 1 0.0042
10 LATEX ALLERGY 1 0.0041
11 GINGIVAL EROSION 1 0.0039
12 VITAMIN D ABNORMAL 1 0.0024
13 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
14 VERTEBRAL OSTEOPHYTE 1 0.0023
15 MAGNESIUM DEFICIENCY 1 0.0021
16 LACRIMATION DECREASED 1 0.0021
17 PERFUME SENSITIVITY 1 0.0018
18 EXTRAVASATION 7 0.0017
19 ADENOMYOSIS 1 0.0017
20 ALLERGY TO CHEMICALS 2 0.0016
21 LEIOMYOMA 1 0.0014
22 MAST CELL ACTIVATION SYNDROME 2 0.0014
23 NASAL ULCER 2 0.0013
24 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
25 MYCOSIS FUNGOIDES 1 0.0012
26 PERIORBITAL PAIN 1 0.0012
27 LIP PRURITUS 1 0.0012
28 ANOGENITAL WARTS 1 0.0011
29 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
30 CATARRH 1 0.0011
31 CERUMEN IMPACTION 1 0.0011
32 HYPOGONADISM 1 0.0010
33 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
34 STEROID WITHDRAWAL SYNDROME 1 0.0010
35 NAIL DISORDER 8 0.0009
36 REACTION TO EXCIPIENT 2 0.0009
37 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
38 HEPATIC INFECTION 1 0.0008
39 BILIARY OBSTRUCTION 1 0.0008
40 APPLICATION SITE PARAESTHESIA 1 0.0008
41 CLUSTER HEADACHE 1 0.0007
42 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
43 GLUTEN SENSITIVITY 1 0.0007
44 VISUAL FIELD DEFECT 5 0.0007
45 SLEEP PARALYSIS 1 0.0007
46 EXCESSIVE EYE BLINKING 1 0.0007
47 AXILLARY PAIN 1 0.0007
48 IMPETIGO 1 0.0007
49 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
50 GENITAL HERPES 1 0.0007
51 ORAL MUCOSAL ERYTHEMA 1 0.0006
52 ONYCHOLYSIS 1 0.0006
53 NON-CARDIAC CHEST PAIN 2 0.0006
54 PAPILLOMA VIRAL INFECTION 1 0.0006
55 SLEEP TALKING 1 0.0006
56 MYCOBACTERIAL INFECTION 1 0.0006
57 ACUTE SINUSITIS 1 0.0006
58 SENSITIVITY OF TEETH 1 0.0006
59 FOOD CRAVING 3 0.0006
60 TERMINAL INSOMNIA 1 0.0006
61 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
62 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
63 LYMPH NODE PAIN 1 0.0005
64 ADRENAL DISORDER 1 0.0005
65 NASAL SEPTUM DEVIATION 1 0.0005
66 OCCULT BLOOD POSITIVE 1 0.0005
67 NAIL DISCOLOURATION 2 0.0005
68 MASS 7 0.0005
69 BLEPHARITIS 2 0.0005
70 EYELID PAIN 1 0.0005
71 CHEST INJURY 1 0.0005
72 CHAPPED LIPS 2 0.0005
73 ONYCHOMYCOSIS 2 0.0005
74 PRODUCT LOT NUMBER ISSUE 1 0.0005
75 EYELID DISORDER 1 0.0004
76 PUSTULE 1 0.0004
77 URINARY HESITATION 1 0.0004
78 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
79 BRONCHITIS CHRONIC 1 0.0004
80 DERMAL CYST 1 0.0004
81 PRODUCT RESIDUE PRESENT 2 0.0004
82 ERYTHEMA OF EYELID 2 0.0004
83 LIP BLISTER 1 0.0004
84 BLOOD PHOSPHORUS INCREASED 1 0.0004
85 OCULAR DISCOMFORT 4 0.0004
86 FIBULA FRACTURE 1 0.0003
87 EYELID MARGIN CRUSTING 1 0.0003
88 NECK INJURY 1 0.0003
89 DYSCHEZIA 1 0.0003
90 MASTICATION DISORDER 1 0.0003
91 SWELLING OF EYELID 2 0.0003
92 RESPIRATORY RATE DECREASED 1 0.0003
93 PHOTOPSIA 2 0.0003
94 SKIN ULCER 8 0.0003
95 PEPTIC ULCER 1 0.0003
96 SKIN MASS 2 0.0003
97 POTENTIATING DRUG INTERACTION 1 0.0003
98 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
99 REGURGITATION 1 0.0003
100 MICTURITION DISORDER 1 0.0003
101 EAR PRURITUS 1 0.0003
102 FRUSTRATION 1 0.0003
103 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
104 HYPERACUSIS 1 0.0003
105 AORTIC ANEURYSM 2 0.0003
106 FAECES HARD 1 0.0003
107 FURUNCLE 2 0.0003
108 HYPERPHAGIA 1 0.0003
109 NOCTURIA 3 0.0002
110 RECURRENT CANCER 1 0.0002
111 APPLICATION SITE EXFOLIATION 1 0.0002
112 THYROID FUNCTION TEST ABNORMAL 1 0.0002
113 ONYCHOMADESIS 1 0.0002
114 SLEEP TERROR 1 0.0002
115 TONGUE DISCOMFORT 1 0.0002
116 FEBRILE BONE MARROW APLASIA 1 0.0002
117 PSEUDOMONAS INFECTION 2 0.0002
118 SKIN HYPERPIGMENTATION 2 0.0002
119 MUSCLE STRAIN 2 0.0002
120 VULVOVAGINAL DISCOMFORT 1 0.0002
121 RHINITIS ALLERGIC 1 0.0002
122 IRON DEFICIENCY 1 0.0002
123 HUNGER 3 0.0002
124 ROSACEA 1 0.0002
125 FEELING OF DESPAIR 1 0.0002
126 PERFORMANCE STATUS DECREASED 1 0.0002
127 EYE INFLAMMATION 2 0.0002
128 SUBCUTANEOUS ABSCESS 1 0.0002
129 TUMOUR MARKER INCREASED 1 0.0002
130 FAECAL INCONTINENCE 1 0.0002
131 APHAGIA 1 0.0002
132 HYPERAMMONAEMIA 1 0.0002
133 DYSLIPIDAEMIA 1 0.0002
134 SLUGGISHNESS 2 0.0002
135 PRODUCT ODOUR ABNORMAL 2 0.0002
136 SCRATCH 2 0.0002
137 LEARNING DISABILITY 1 0.0002
138 PRODUCT SIZE ISSUE 1 0.0002
139 CHEILITIS 1 0.0002
140 PULMONARY THROMBOSIS 2 0.0002
141 PERIORBITAL SWELLING 1 0.0002
142 SCAR 3 0.0002
143 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
144 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
145 CONJUNCTIVITIS 3 0.0002
146 PRE-EXISTING CONDITION IMPROVED 1 0.0002
147 FOREIGN BODY SENSATION IN EYES 1 0.0002
148 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
149 THROAT IRRITATION 7 0.0002
150 PROCTALGIA 1 0.0002
151 APPLICATION SITE VESICLES 1 0.0002
152 POLYP 1 0.0002
153 SOMNAMBULISM 1 0.0002
154 PRODUCT FORMULATION ISSUE 1 0.0002
155 VISUAL ACUITY REDUCED 5 0.0002
156 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
157 TONGUE DISORDER 1 0.0001
158 FAECES SOFT 1 0.0001
159 ORAL DISORDER 1 0.0001
160 SKIN HAEMORRHAGE 2 0.0001
161 FEELING DRUNK 1 0.0001
162 SUNBURN 1 0.0001
163 PHARYNGEAL OEDEMA 2 0.0001
164 FOOD ALLERGY 1 0.0001
165 APHTHOUS ULCER 1 0.0001
166 ACUTE MYELOID LEUKAEMIA 2 0.0001
167 MULTIPLE ALLERGIES 1 0.0001
168 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
169 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
170 OCULAR HYPERAEMIA 6 0.0001
171 ABSCESS 2 0.0001
172 HICCUPS 1 0.0001
173 ESCHERICHIA INFECTION 1 0.0001
174 AGEUSIA 3 0.0001
175 SKIN DISORDER 4 0.0001
176 MUSCULOSKELETAL DISCOMFORT 2 0.0001
177 BLOOD MAGNESIUM DECREASED 1 0.0001
178 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
179 SEDATION 3 0.0001
180 SPINAL OSTEOARTHRITIS 1 0.0001
181 THIRST 2 0.0001
182 PAIN OF SKIN 3 0.0001
183 GASTROENTERITIS VIRAL 2 0.0001
184 TOOTHACHE 2 0.0001
185 VISION BLURRED 15 0.0001
186 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
187 NEUROPATHY PERIPHERAL 10 0.0001
188 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
189 DRUG PRESCRIBING ERROR 2 0.0001
190 LOWER LIMB FRACTURE 2 0.0001
191 AFFECT LABILITY 1 0.0001
192 HERNIA 2 0.0001
193 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
194 VITAMIN D DEFICIENCY 1 0.0001
195 LABORATORY TEST ABNORMAL 3 0.0001
196 LIGAMENT SPRAIN 1 0.0001
197 ABNORMAL BEHAVIOUR 4 0.0001
198 TEMPERATURE INTOLERANCE 1 0.0001
199 EYE DISCHARGE 1 0.0001
200 DERMATITIS 2 0.0001
201 JOINT DISLOCATION 1 0.0001
202 JOINT INJURY 2 0.0001
203 BODY HEIGHT DECREASED 1 0.0001
204 BACK INJURY 1 0.0001
205 OESOPHAGITIS 1 0.0001
206 ASPIRATION 1 0.0001
207 FUNGAL INFECTION 3 0.0001
208 TOOTH DISORDER 2 0.0001
209 MALNUTRITION 1 0.0001
210 EYE PRURITUS 3 0.0001
211 SKIN INFECTION 1 0.0001
212 REBOUND EFFECT 1 0.0001
213 IMPAIRED DRIVING ABILITY 1 0.0001
214 MICTURITION URGENCY 1 0.0001
215 SKIN IRRITATION 4 0.0001
216 NEOPLASM 1 0.0001
217 BLOOD CHOLESTEROL INCREASED 4 0.0001
218 WRIST FRACTURE 1 0.0001
219 MENTAL IMPAIRMENT 2 0.0001
220 FIBROMYALGIA 2 0.0001
221 NEURALGIA 2 0.0001
222 CYTOPENIA 1 0.0001
223 APPLICATION SITE IRRITATION 1 0.0001
224 SECRETION DISCHARGE 1 0.0001
225 DERMATITIS ALLERGIC 1 0.0001
226 UNEVALUABLE EVENT 6 0.0001
227 ACNE 6 0.0001
228 ROTATOR CUFF SYNDROME 1 0.0001
229 IMMUNE SYSTEM DISORDER 1 0.0001
230 TOOTH INFECTION 1 0.0001
231 DISORIENTATION 3 0.0001
232 HAIR TEXTURE ABNORMAL 1 0.0001
233 JOINT RANGE OF MOTION DECREASED 1 0.0001
234 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
235 RASH PRURITIC 4 0.0001
236 LIMB INJURY 2 0.0001
237 IMPAIRED GASTRIC EMPTYING 1 0.0001
238 BURNING SENSATION 5 0.0001
239 SKIN REACTION 1 0.0001
240 EYE PAIN 4 0.0001
241 PAIN IN JAW 2 0.0001
242 IMPAIRED QUALITY OF LIFE 1 0.0001
243 EYE IRRITATION 4 0.0001
244 PARAESTHESIA ORAL 1 0.0001
245 ANOSMIA 1 0.0001
246 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
247 HYPOAESTHESIA ORAL 1 0.0001
248 OSTEOPENIA 1 0.0001
249 VERTIGO 4 0.0001
250 TENDONITIS 1 0.0001
251 SWOLLEN TONGUE 2 0.0001
252 PRODUCT USE COMPLAINT 1 0.0001
253 HALLUCINATION, AUDITORY 1 0.0001
254 CYSTITIS 2 0.0001
255 OBESITY 1 0.0001
256 MOOD SWINGS 2 0.0001
257 HYPOTHYROIDISM 2 0.0001
258 SENSORY DISTURBANCE 1 0.0001
259 SWELLING FACE 4 0.0001
260 EYE DISORDER 2 0.0001
261 PHOTOSENSITIVITY REACTION 1 0.0001
262 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
263 CANDIDA INFECTION 1 0.0001
264 HAEMATURIA 2 0.0001
265 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
266 ECZEMA 3 0.0001
267 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
268 SKIN BURNING SENSATION 4 0.0001
269 GOUT 1 0.0001
270 DISTURBANCE IN ATTENTION 3 0.0001
271 RESTLESS LEGS SYNDROME 1 0.0001
272 PANIC ATTACK 2 0.0001
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
274 RESTLESSNESS 2 0.0001
275 EYE SWELLING 2 0.0001
276 ABDOMINAL PAIN UPPER 11 0.0001
277 PHOTOPHOBIA 1 0.0001
278 BLOOD URINE PRESENT 1 0.0001
279 FEELING JITTERY 1 0.0001
280 MIGRAINE 5 0.0001
281 ERUCTATION 1 0.0001
282 EAR PAIN 1 0.0001
283 HAEMORRHOIDS 1 0.0001
284 PLASMA CELL MYELOMA 2 0.0001
285 ORAL HERPES 1 0.0001
286 SKIN FISSURES 1 0.0001
287 KIDNEY INFECTION 1 0.0001
288 CYTOKINE RELEASE SYNDROME 1 0.0000
289 FULL BLOOD COUNT DECREASED 1 0.0000
290 BODY TEMPERATURE INCREASED 1 0.0000
291 SINUSITIS 5 0.0000
292 RIB FRACTURE 1 0.0000
293 HYPERSENSITIVITY 9 0.0000
294 POLLAKIURIA 2 0.0000
295 ROAD TRAFFIC ACCIDENT 2 0.0000
296 HALLUCINATION, VISUAL 1 0.0000
297 ABDOMINAL PAIN 11 0.0000
298 EATING DISORDER 1 0.0000
299 RETCHING 1 0.0000
300 IMPAIRED WORK ABILITY 1 0.0000
301 POOR QUALITY SLEEP 1 0.0000
302 SKIN CANCER 1 0.0000
303 RHINORRHOEA 3 0.0000
304 ALOPECIA 9 0.0000
305 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
306 APPLICATION SITE PAIN 1 0.0000
307 DEHYDRATION 6 0.0000
308 DRY SKIN 6 0.0000
309 ORAL PAIN 1 0.0000
310 PARAESTHESIA 7 0.0000
311 MUSCLE TWITCHING 1 0.0000
312 COGNITIVE DISORDER 2 0.0000
313 LOCALISED INFECTION 1 0.0000
314 PRESYNCOPE 1 0.0000
315 ENCEPHALOPATHY 1 0.0000
316 BRONCHITIS 3 0.0000
317 DYSGEUSIA 3 0.0000
318 VISUAL IMPAIRMENT 5 0.0000
319 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
320 HYPOAESTHESIA 6 0.0000
321 PNEUMONIA ASPIRATION 1 0.0000
322 HALLUCINATION 3 0.0000
323 CONDITION AGGRAVATED 12 0.0000
324 FLUSHING 4 0.0000
325 CHEST DISCOMFORT 4 0.0000
326 PRURITUS 15 0.0000
327 DIPLOPIA 1 0.0000
328 RESPIRATORY TRACT INFECTION 1 0.0000
329 SPEECH DISORDER 2 0.0000
330 APPLICATION SITE ERYTHEMA 1 0.0000
331 BLOOD BILIRUBIN INCREASED 1 0.0000
332 CONSTIPATION 8 0.0000
333 ABNORMAL DREAMS 1 0.0000
334 TREATMENT FAILURE 3 0.0000
335 DIVERTICULITIS 1 0.0000
336 MENTAL STATUS CHANGES 1 0.0000
337 INFLUENZA 4 0.0000
338 URTICARIA 6 0.0000
339 PANCYTOPENIA 2 0.0000
340 SKIN EXFOLIATION 3 0.0000
341 HYPONATRAEMIA 2 0.0000
342 RED BLOOD CELL COUNT DECREASED 1 0.0000
343 RASH 15 0.0000
344 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
345 NAUSEA 27 0.0000
346 ACUTE MYOCARDIAL INFARCTION 1 0.0000
347 PSYCHOTIC DISORDER 1 0.0000
348 RESPIRATORY DISORDER 1 0.0000
349 FATIGUE 26 0.0000
350 APHASIA 1 0.0000
351 LACRIMATION INCREASED 1 0.0000
352 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
353 STOMATITIS 2 0.0000
354 ILL-DEFINED DISORDER 2 0.0000
355 MUSCLE SPASMS 6 0.0000
356 PAIN 20 0.0000
357 NASOPHARYNGITIS 6 0.0000
358 SWELLING 3 0.0000
359 NERVOUS SYSTEM DISORDER 1 0.0000
360 PRODUCT USE ISSUE 6 0.0000
361 CONTUSION 3 0.0000
362 MOVEMENT DISORDER 1 0.0000
363 NIGHT SWEATS 1 0.0000
364 DYSPEPSIA 3 0.0000
365 STAPHYLOCOCCAL INFECTION 1 0.0000
366 FEBRILE NEUTROPENIA 2 0.0000
367 BLOOD PRESSURE DECREASED 2 0.0000
368 VIRAL INFECTION 1 0.0000
369 LIP SWELLING 1 0.0000
370 INJECTION SITE PRURITUS 2 0.0000
371 ABDOMINAL DISCOMFORT 5 0.0000
372 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
373 ILLNESS 3 0.0000
374 NEOPLASM PROGRESSION 1 0.0000
375 HAEMORRHAGE 3 0.0000
376 RASH MACULAR 1 0.0000
377 LYMPHADENOPATHY 1 0.0000
378 CRYING 1 0.0000
379 HYPERGLYCAEMIA 1 0.0000
380 ACCIDENTAL OVERDOSE 1 0.0000
381 EPISTAXIS 2 0.0000
382 DECREASED APPETITE 6 0.0000
383 ARTHRITIS 2 0.0000
384 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
385 DRUG INTERACTION 4 0.0000
386 WEIGHT DECREASED 7 0.0000
387 FEELING ABNORMAL 6 0.0000
388 THROMBOSIS 2 0.0000
389 SOMNOLENCE 5 0.0000
390 CONFUSIONAL STATE 4 0.0000
391 DRY MOUTH 2 0.0000
392 OEDEMA PERIPHERAL 3 0.0000
393 INJECTION SITE ERYTHEMA 3 0.0000
394 URINARY TRACT INFECTION 4 0.0000
395 VOMITING 11 0.0000
396 RECTAL HAEMORRHAGE 1 0.0000
397 HYPOACUSIS 1 0.0000
398 BALANCE DISORDER 2 0.0000
399 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
400 THERAPY NON-RESPONDER 1 0.0000
401 NEPHROLITHIASIS 1 0.0000
402 SKIN DISCOLOURATION 1 0.0000
403 HYPOKALAEMIA 1 0.0000
404 OROPHARYNGEAL PAIN 2 0.0000
405 CHEST PAIN 4 0.0000
406 RENAL DISORDER 1 0.0000
407 COUGH 6 0.0000
408 MULTIPLE SCLEROSIS 1 0.0000
409 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
410 LUNG DISORDER 1 0.0000
411 DRY EYE 1 0.0000
412 CELLULITIS 1 0.0000
413 PERIPHERAL SWELLING 3 0.0000
414 ERYTHEMA 4 0.0000
415 INFLAMMATION 1 0.0000
416 ABDOMINAL DISTENSION 2 0.0000
417 HEADACHE 12 0.0000
418 DERMATITIS ATOPIC 1 0.0000
419 PLATELET COUNT DECREASED 2 0.0000
420 PNEUMONIA 6 0.0000
421 OEDEMA 1 0.0000
422 MALAISE 8 0.0000
423 HAEMATOCHEZIA 1 0.0000
424 ARTHROPATHY 1 0.0000
425 NECK PAIN 1 0.0000
426 WEIGHT INCREASED 4 0.0000
427 BLISTER 1 0.0000
428 ASTHMA 2 0.0000
429 DYSPNOEA 10 0.0000
430 MUSCULAR WEAKNESS 2 0.0000
431 DEPRESSION 4 0.0000
432 ANXIETY 5 0.0000
433 LETHARGY 1 0.0000
434 PRODUCT SUBSTITUTION ISSUE 1 0.0000
435 COVID-19 3 0.0000
436 PALPITATIONS 2 0.0000
437 BONE PAIN 1 0.0000
438 CHILLS 2 0.0000
439 ARTHRALGIA 7 0.0000
440 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
441 IRRITABILITY 1 0.0000
442 DISCOMFORT 1 0.0000
443 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
444 ASTHENIA 6 0.0000
445 DRUG INEFFECTIVE 21 0.0000
446 GAIT DISTURBANCE 3 0.0000
447 LOSS OF CONSCIOUSNESS 2 0.0000
448 AMNESIA 1 0.0000
449 PRODUCT DOSE OMISSION 1 0.0000
450 PSORIASIS 2 0.0000
451 MEMORY IMPAIRMENT 2 0.0000
452 INJECTION SITE REACTION 1 0.0000
453 SLEEP DISORDER 1 0.0000
454 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
455 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
456 MOBILITY DECREASED 1 0.0000
457 RESPIRATORY FAILURE 1 0.0000
458 UNDERDOSE 1 0.0000
459 AGITATION 1 0.0000
460 PRODUCT DOSE OMISSION ISSUE 4 0.0000
461 DIABETES MELLITUS 1 0.0000
462 INJECTION SITE SWELLING 1 0.0000
463 BACK PAIN 3 0.0000
464 INJECTION SITE BRUISING 1 0.0000
465 CARDIAC FAILURE CONGESTIVE 1 0.0000
466 INFLUENZA LIKE ILLNESS 1 0.0000
467 DIZZINESS 6 0.0000
468 FALL 4 0.0000
469 RENAL IMPAIRMENT 1 0.0000
470 MYALGIA 2 0.0000
471 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
472 MUSCULOSKELETAL STIFFNESS 1 0.0000
473 INSOMNIA 3 0.0000
474 TACHYCARDIA 1 0.0000
475 GASTROINTESTINAL DISORDER 1 0.0000
476 SUICIDAL IDEATION 1 0.0000
477 DIARRHOEA 7 0.0000
478 CARDIAC DISORDER 1 0.0000
479 BLOOD GLUCOSE INCREASED 2 0.0000
480 DYSPHAGIA 1 0.0000
481 ANAEMIA 2 0.0000
482 DRUG INTOLERANCE 1 0.0000
483 ATRIAL FIBRILLATION 1 0.0000
484 PAIN IN EXTREMITY 3 0.0000
485 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
486 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
487 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
488 OFF LABEL USE 8 0.0000
489 SEPSIS 1 0.0000
490 DISEASE PROGRESSION 1 0.0000
491 JOINT SWELLING 1 0.0000
492 EMOTIONAL DISTRESS 1 0.0000
493 HYPERHIDROSIS 1 0.0000
494 PRODUCT QUALITY ISSUE 1 0.0000
495 INFECTION 1 0.0000
496 BLOOD PRESSURE INCREASED 1 0.0000
497 TREMOR 1 0.0000
498 MYOCARDIAL INFARCTION 1 0.0000
499 HYPERTENSION 1 0.0000
500 OVERDOSE 1 0.0000
501 INCORRECT DOSE ADMINISTERED 1 0.0000
502 INJECTION SITE PAIN 1 0.0000
503 PYREXIA 1 0.0000
504 DEATH 2 0.0000